CELG - Celgene Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
16,982,000
15,281,000
13,003,000
11,229,200
9,256,000
Cost of Revenue
627,000
587,000
461,000
438,000
420,100
Gross Profit
16,355,000
14,694,000
12,542,000
10,791,200
8,835,900
Operating Expenses
Research Development
4,621,000
5,673,000
5,915,000
4,470,100
3,697,300
Selling General and Administrative
3,197,000
3,250,000
2,941,000
2,657,700
2,305,400
Total Operating Expenses
8,272,000
9,391,000
9,185,000
7,586,800
6,281,700
Operating Income or Loss
8,083,000
5,303,000
3,357,000
3,204,400
2,554,200
Interest Expense
764,000
741,000
522,000
500,100
310,600
Total Other Income/Expenses Net
-782,000
225,000
1,374,000
-362,100
-251,200
Income Before Tax
6,669,000
4,832,000
4,314,000
2,372,500
2,023,500
Income Tax Expense
789,000
786,000
1,374,000
373,300
421,500
Income from Continuing Operations
5,880,000
4,046,000
2,940,000
1,999,200
1,602,000
Net Income
5,880,000
4,046,000
2,940,000
1,999,200
1,602,000
Net Income available to common shareholders
5,880,000
4,046,000
2,940,000
1,999,200
1,602,000
Reported EPS
Basic
-
5.65
3.77
2.57
2.02
Diluted
-
5.51
3.64
2.49
1.94
Weighted average shares outstanding
Basic
-
716,300
779,200
777,200
792,200
Diluted
-
733,800
808,700
803,300
824,900
EBITDA
-
6,041,000
5,165,000
3,331,600
2,613,100